Press releases - 03 March 2022 16:00 CET
ZINZINO AB (PUBL): PRELIMINARY SALES REPORT FEBRUARY 2022
Zinzino group revenue decreased with a total of 5%, compared with the previous year.
The revenue in February for Zinzino's sales markets decreased by 4% and amounted to SEK 88.5 (92.6) million. Faun Pharma's external sales decreased by 7% and amounted to SEK 6.3 (6.8) million. Overall, the Group decreased revenues by 5% to SEK 94.8 (99.4) million compared with the previous year.
Accumulated revenue for January – February 2022 decreased by 1% to SEK 204.5 (206.4) million.
Revenues were distributed as follows:
|Regions,MSEK||22-Feb||21-Feb||Change||YTD 2022||YTD 2021||Change|
|South & West Europe||11.3||9.9||14%||23.7||20.0||19%|
Countries in regions:
-The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden
-Central Europe: Austria, Germany, Switzerland
-East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania
-South & West Europe: Cyprus, France, Greece, Italy, Netherlands, Spain, United Kingdom, Belgium, Ireland
-The Baltics: Estonia, Latvia, Lithuania
-North America: Canada, USA
-Asia-Pacific: Australia, Hong Kong, India, Malaysia, Singapore, Taiwan, Thailand
-Africa: South Africa
For more information:
Dag Bergheim Pettersen CEO Zinzino +47 (0) 932 25 700, zinzino.com
Pictures for publication free of charge:
Marcus Tollbom +46 (0) 70 190 03 12, firstname.lastname@example.org
Certified Adviser: Erik Penser Bank Aktiebolag, +46 (0) 8 463 83 00, email: email@example.com
This disclosure contains information that Zinzino is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was submitted for publication, through the agency of the contact person, at 16:00 the 3rd of March 2022.